Two activating mutations of MPL in triple‐negative myeloproliferative neoplasms
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Two activating mutations of
MPL
in triple‐negative myeloproliferative neoplasms
Authors
Keywords
-
Journal
Cancer Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-07-11
DOI
10.1002/cam4.2387
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomics of Myeloproliferative Neoplasms
- (2017) Katerina Zoi et al. JOURNAL OF CLINICAL ONCOLOGY
- An unusual, activating insertion/deletion MPL mutant in primary myelofibrosis
- (2017) J-P Defour et al. LEUKEMIA
- Thrombopoietin receptor is required for the oncogenic function of CALR mutants
- (2016) H Nivarthi et al. LEUKEMIA
- Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms
- (2015) J. D. Milosevic Feenstra et al. BLOOD
- Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants
- (2015) I. Chachoua et al. BLOOD
- Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients
- (2015) X. Cabagnols et al. BLOOD
- His499Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor
- (2015) Emilie Leroy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms
- (2015) J-P Defour et al. LEUKEMIA
- Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms
- (2013) E. Rumi et al. BLOOD
- Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases
- (2013) Xin He et al. Journal of Hematology & Oncology
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation
- (2013) J.-P. Defour et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of MPL exon10 mutations in 103 Chinese patients with JAK2V617F-negative myeloproliferative neoplasms
- (2011) Xiuhua Chen et al. BLOOD CELLS MOLECULES AND DISEASES
- MPL Mutation Profile in JAK2 Mutation-negative Patients With Myeloproliferative Disorders
- (2011) Wanlong Ma et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Orientation-specific signalling by thrombopoietin receptor dimers
- (2011) Judith Staerk et al. EMBO JOURNAL
- Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation
- (2011) Erin E. Matthews et al. FASEB JOURNAL
- Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor
- (2009) C. Pecquet et al. BLOOD
- Two rare MPL gene mutations in patients with essential thrombocythemia
- (2009) Haruhiko Ohashi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition
- (2008) R Chaligné et al. LEUKEMIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started